{
    "organizations": [],
    "uuid": "a3ede21364da5bbf950986943be6f00908d5e323",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-agios-says-fda-accepts-nda-and-gra/brief-agios-says-fda-accepts-nda-and-grants-priority-review-for-ivosidenib-idUSASB0C60U",
    "ord_in_thread": 0,
    "title": "BRIEF-Agios says FDA Accepts NDA And Grants Priority Review For Ivosidenib",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Agios Pharmaceuticals Inc:\n* FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION\n* FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION\n* AGIOS PHARMACEUTICALS INC - ‍PDUFA DATE SET FOR AUGUST 21, 2018​\n* AGIOS PHARMACEUTICALS - ABBOTT SUBMITTED PREMARKET APPROVAL APPLICATION FOR FDA REVIEW OF AN IDH1 ASSAY ON ABBOTT M2000 REALTIME SYSTEM​\n* AGIOS PHARMACEUTICALS INC - ‍ABBOTT ASSAY WILL SERVE AS A COMPANION DIAGNOSTIC FOR IVOSIDENIB​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T01:08:00.000+02:00",
    "crawled": "2018-02-16T16:52:07.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "agio",
        "pharmaceutical",
        "inc",
        "fda",
        "accepts",
        "new",
        "drug",
        "application",
        "grant",
        "priority",
        "review",
        "ivosidenib",
        "relapsed",
        "refractory",
        "aml",
        "idh1",
        "mutation",
        "fda",
        "accepts",
        "new",
        "drug",
        "application",
        "grant",
        "priority",
        "review",
        "ivosidenib",
        "relapsed",
        "refractory",
        "aml",
        "idh1",
        "mutation",
        "agio",
        "pharmaceutical",
        "inc",
        "date",
        "set",
        "august",
        "agio",
        "pharmaceutical",
        "abbott",
        "submitted",
        "premarket",
        "approval",
        "application",
        "fda",
        "review",
        "idh1",
        "assay",
        "abbott",
        "m2000",
        "realtime",
        "agio",
        "pharmaceutical",
        "inc",
        "assay",
        "serve",
        "companion",
        "diagnostic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}